HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

U Nishiyama Selected Research

Ki23819

6/2005Identification of Ki23819, a highly potent inhibitor of kinase activity of mutant FLT3 receptor tyrosine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


U Nishiyama Research Topics

Disease

1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2005
1Leukemia
06/2005
1Thrombosis (Thrombus)
02/2005
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2005

Drug/Important Bio-Agent (IBA)

1Ki23819IBA
06/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2005
1fms-Like Tyrosine Kinase 3IBA
06/2005
1polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)IBA
02/2005

Therapy/Procedure

1Drug Therapy (Chemotherapy)
06/2005
1Intravenous Injections
02/2005